Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Hon Pui

Showing results (481-490 of 611) with videos related to

Pageof 62
Sort By:
Plos Computational Biology|February 5, 2016
MicroRNAs Form Triplexes with Double Stranded DNA at Sequence-Specific Binding Sites; a Eukaryotic Mechanism via which microRNAs Could Directly Alter Gene ExpressionSteven W Paugh, David R Coss, Ju Bao, et al.
Blood|May 28, 2025
Differentiation-dependent EBF1 activity determines CD22 transcription and leukemia sensitivity to inotuzumab ozogamicinCarolin S Escherich, Zhenhua Li, Kelly R Barnett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2023
Outcome for Children and Young Adults With T-Cell ALL and Induction Failure in Contemporary TrialsElizabeth A Raetz, Paola Rebora, Valentino Conter, et al.
The Lancet. Haematology|July 8, 2026
Venetoclax in combination with cytarabine with or without idarubicin or azacitidine in children, adolescents, and young adults with relapsed or refractory acute myeloid leukaemia (VENAML): a multicentre, phase 1 expansion studyKatelyn P Daniels, Stanley B Pounds, Huiyun Wu, et al.
Children (Basel, Switzerland)|December 24, 2021
Pediatric Cardio-Oncology Medicine: A New Approach in Cardiovascular CareHugo R Martinez, Gary S Beasley, Jason F Goldberg, et al.
Cancer|August 13, 2024
Delineation of features, responses, outcomes, and prognostic factors in pediatric PDGFRB-positive acute lymphoblastic leukemia patients: A retrospective multicenter studyXiaoyan Zhang, Yaqin Wang, Xin Tian, et al.
Clinical Pharmacology and Therapeutics|January 31, 2026
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 UpdateMaud Maillard, Matthias Schwab, Michelle Whirl-Carrillo, et al.
Nature Communications|February 13, 2016
A variant at 9p21.3 functionally implicates CDKN2B in paediatric B-cell precursor acute lymphoblastic leukaemia aetiologyEric A Hungate, Sapana R Vora, Eric R Gamazon, et al.
Cancer Cell|June 28, 2002
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profilingEng-Juh Yeoh, Mary E Ross, Sheila A Shurtleff, et al.
Clinical Pharmacology and Therapeutics|March 26, 2021
Class II Human Leukocyte Antigen Variants Associate With Risk of Pegaspargase HypersensitivityYiwei Liu, Wenjian Yang, Colton A Smith, et al.
Pageof 62

Showing results (481-490 of 611) with videos related to

Sort By:
Pageof 62
Plos Computational Biology|February 5, 2016
MicroRNAs Form Triplexes with Double Stranded DNA at Sequence-Specific Binding Sites; a Eukaryotic Mechanism via which microRNAs Could Directly Alter Gene ExpressionSteven W Paugh, David R Coss, Ju Bao, et al.
Blood|May 28, 2025
Differentiation-dependent EBF1 activity determines CD22 transcription and leukemia sensitivity to inotuzumab ozogamicinCarolin S Escherich, Zhenhua Li, Kelly R Barnett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2023
Outcome for Children and Young Adults With T-Cell ALL and Induction Failure in Contemporary TrialsElizabeth A Raetz, Paola Rebora, Valentino Conter, et al.
The Lancet. Haematology|July 8, 2026
Venetoclax in combination with cytarabine with or without idarubicin or azacitidine in children, adolescents, and young adults with relapsed or refractory acute myeloid leukaemia (VENAML): a multicentre, phase 1 expansion studyKatelyn P Daniels, Stanley B Pounds, Huiyun Wu, et al.
Children (Basel, Switzerland)|December 24, 2021
Pediatric Cardio-Oncology Medicine: A New Approach in Cardiovascular CareHugo R Martinez, Gary S Beasley, Jason F Goldberg, et al.
Cancer|August 13, 2024
Delineation of features, responses, outcomes, and prognostic factors in pediatric PDGFRB-positive acute lymphoblastic leukemia patients: A retrospective multicenter studyXiaoyan Zhang, Yaqin Wang, Xin Tian, et al.
Clinical Pharmacology and Therapeutics|January 31, 2026
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 UpdateMaud Maillard, Matthias Schwab, Michelle Whirl-Carrillo, et al.
Nature Communications|February 13, 2016
A variant at 9p21.3 functionally implicates CDKN2B in paediatric B-cell precursor acute lymphoblastic leukaemia aetiologyEric A Hungate, Sapana R Vora, Eric R Gamazon, et al.
Cancer Cell|June 28, 2002
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profilingEng-Juh Yeoh, Mary E Ross, Sheila A Shurtleff, et al.
Clinical Pharmacology and Therapeutics|March 26, 2021
Class II Human Leukocyte Antigen Variants Associate With Risk of Pegaspargase HypersensitivityYiwei Liu, Wenjian Yang, Colton A Smith, et al.
Pageof 62